LIVE
Login☆ WatchlistAPI Docs
Markets
NSE StocksBSE StocksF&ORates & G-SecsCurrenciesSectorsCommodities
News
Corporate AnnouncementsGovernment & PolicyFixed IncomeETFsFXAlt. InvestingEconomic Calendar
Sections
EconomicsTechFinancePoliticsWealth
Language
Englishहिन्दीગુજરાતીमराठी

GLENMARK

NSEBSE
F&O
Glenmark Pharmaceuticals Limited
Healthcare· Pharmaceuticals & Biotechnology· INE935A01035· Scrip: 532296
ENहिन्दीગુજરાતીमराठी
२,३७१.४०
46.50 (-1.92%)
6/5/2026, 3:28:22 pm
NSE
२,३७१.४०
४६.५०
-१.९२%
BSE
२,३७३.७५
४६.३०
+०.००%
1,3731,6371,9022,1662,43005-0607-0108-2810-2712-2302-2004-2905-06
२४५ कारोबारी दिन · 1Y अवधि
आज
खुलना२,४३५.००
उच्च२,४४०.००
निम्न२,३५४.९०
पिछला बंद२,४१७.९०
मात्रा१०.९८L
मूल्य₹२६४.८Cr
L: 2,354.90H: 2,440.00
52 सप्ताह
निम्न१,३५५.४०
उच्च२,४७४.००
९१% 52 सप्ताह की सीमा में
जानकारी
अंकित मूल्य₹१
सूचीबद्ध2000-02-07
ISININE935A01035
SeriesA
BSE स्क्रिप532296

मुख्य संकेतक

1D
-1.92%
1W
-1.34%
1M
+12.86%
3M
+20.52%
6M
+28.14%
मूल्यांकन
P/E (Qtr Ann.)४८.०८
P/Sales५.०४
वृद्धि (तिमाही)
PAT-1.82%
EPS-1.75%
लाभप्रदता
TTM EBITDA M.२०.७%

त्रैमासिक वित्तीय

राजस्व
EBITDA
PAT
EPS
0 Cr866 Cr1732 Cr2598 Cr3464 Cr22-1223-0323-0923-1224-0324-0624-0924-129.7-15.2-2.9-12.4-43.216.112.612.3
तिमाहीराजस्वExpensesEBITDAPBTPATEPS
2024-12-313388 Cr2962 Cr579 Cr456 Cr348 Cr12.33
2024-09-303434 Cr3001 Cr593 Cr473 Cr354 Cr12.55
2024-06-302330 Cr1767 Cr671 Cr618 Cr454 Cr16.08
2024-03-313063 Cr2859 Cr682 Cr531 Cr-1214 Cr-43.18
2023-12-312507 Cr2997 Cr-374 Cr-521 Cr-331 Cr-12.45
2023-09-303207 Cr3008 Cr17 Cr-124 Cr-64 Cr-2.90
2023-03-313374 Cr3025 Cr-344 Cr-491 Cr-403 Cr-15.18
2022-12-313464 Cr3103 Cr633 Cr471 Cr291 Cr9.66

शेयरधारिता पैटर्न

वर्तमान2026-03-31
46.6%प्रमोटर
प्रमोटर46.6%
FII20.3%
DII19.3%
सार्वजनिक53.4%
सरकार0.0%
प्रमोटर होल्डिंग ट्रेंड
46.6%24-0646.6%24-0946.6%24-1246.6%25-0346.6%25-0946.6%25-1246.6%26-03

कॉर्पोरेट कार्यवाही

एक्स-तारीखप्रकारउद्देश्य
2025-10-03DividendInterim Dividend - Rs 2.50 Per Share
2025-09-15DividendDividend - Rs 2.50 Per Share
2024-09-13DividendDividend - Rs 2.50 Per Share
2023-09-18DividendDividend - Rs 2.50 Per Share
2022-09-12DividendAnnual General Meeting/Dividend - Rs 2.50 Per Share
2021-09-08Dividend Annual General Meeting/Dividend - Rs 2.50 Per Share
2020-09-17Dividend Annual General Meeting/Dividend - Rs 2.50 Per Share
2019-09-19Dividend Annual General Meeting/Dividend - Rs 2 Per Share
2018-09-19Dividend Annual General Meeting/Dividend Rs 2 Per Share
2017-09-20Dividend Annual General Meeting/Dividend - Rs 2/- Per Share
2016-08-03Dividend Annual General Meeting/ Dividend - Rs 2/- Per Share
2015-09-10Dividend Annual General Meeting/ Dividend - Rs 2/- Per Share
2014-07-10DividendAnnual General Meeting / Dividend - Rs 2/- Per Share
2013-07-18DividendAnnual General Meeting / Dividend - Rs 2/- Per Share
2012-07-19DividendAnnual General Meeting / Dividend Rs 2 Per Share
2011-07-28DividendAnnual General Meeting And Dividend Re.0.40 Per Share
2010-09-16DividendAnnual General Meeting And Dividend Re.0.40 Per Share
2009-09-10OtherAgm/Div-Re.0.40 Per Share
2008-09-18OtherAnnual General Meeting
2007-11-07DividendInterim Dividend-70% Purpose Revised

आय विवरण

Glenmark Pharmaceuticals Limited has informed the Exchange about Investor Presentation
14 Nov 2025NSE20K chars
Read →
Glenmark Pharmaceuticals Limited has informed the Exchange about Investor Presentation
14 Aug 2025NSE14K chars
Read →
Glenmark Pharmaceuticals Limited has informed the Exchange about Investor Presentation
23 May 2025NSE18K chars
Read →
Glenmark Pharmaceuticals Limited has informed the Exchange about Investor Presentation
14 Feb 2025NSE18K chars
Read →
Glenmark Pharmaceuticals Limited has informed the Exchange about Investor Presentation
14 Feb 2024NSE20K chars
Read →
Glenmark Pharmaceuticals Limited has informed the Exchange about Investor Presentation
10 Nov 2023NSE24K chars
Read →
Glenmark Pharmaceuticals Limited has informed the Exchange about Investor Presentation
21 Sept 2023NSE11K chars
Read →
Glenmark Pharmaceuticals Limited has informed the Exchange about Investor Presentation
19 May 2023NSE22K chars
Read →
Glenmark Pharmaceuticals Limited has informed the Exchange about Investor Presentation
10 Feb 2023NSE20K chars
Read →
Further to our letter dated 03rd November, 2022 and pursuant to Regulation 30(6) read with Part A of...
18 Nov 2022NSE1K chars
Read →
Further to our communication dated November 11, 2022, attached is a copy of the presentation to be m...
17 Nov 2022NSE42K chars
Read →
Audio recording of Q2 of FY 2022-23 Earnings Call
14 Nov 2022NSE1K chars
Read →
Enclosed please find herewith the details of Earnings Call slated for Monday, November 14, 2022 at 9...
3 Nov 2022NSE2K chars
Read →
Further to our letter dated 01st August, 2022 and pursuant to Regulation 30(6) read with Part A of S...
17 Aug 2022NSE2K chars
Read →
Glenmark Pharmaceuticals Limited has informed the Exchange about Audio recording of Q1 of FY 2022-23...
12 Aug 2022NSE1K chars
Read →
Glenmark Pharmaceuticals Limited has informed the Exchange about Transcript of Analysts/Institutiona...
3 Jun 2022NSE1K chars
Read →
Glenmark Pharmaceuticals Limited has informed the Exchange about Audio recording of Q4 & FY22 Earnin...
30 May 2022NSE1K chars
Read →
Glenmark Pharmaceuticals Limited has informed the Exchange regarding "Investor Presentation of the C...
12 Jan 2016NSE
Read →
Glenmark Pharmaceuticals Limited has submitted to the Exchange a copy of the Investor Presentation o...
14 Jan 2015NSE
Read →

मूल्य इतिहास

तारीखखुलनाउच्चनिम्नबंदमात्रा
2026-05-06२,४३५.००२,४४०.००२,३५४.९०२,३७७.६०११.०९L
2026-05-05२,३८४.३०२,४३०.००२,३६०.००२,४१७.९०९.१८L
2026-05-04२,४३४.३०२,४३८.८०२,३८२.६०२,३९३.७०४.५१L
2026-04-30२,४००.१०२,४५५.९०२,३८५.६०२,४०६.३०७.९३L
2026-04-29२,४१८.७०२,४७४.००२,४०३.७०२,४१३.९०६.१७L
2026-04-28२,३२८.१०२,४२७.४०२,३२७.३०२,४०३.७०१५.३८L
2026-04-27२,३१२.००२,३३९.९०२,२९०.९०२,३२५.१०४.६३L
2026-04-24२,३५१.००२,३७२.८०२,२८३.२०२,२९९.५०८.३८L
2026-04-23२,२४७.९०२,३५९.४०२,२१२.१०२,३३५.००१७.०४L
2026-04-22२,२३३.१०२,२४७.००२,२०४.८०२,२४०.००३.२३L
2026-04-21२,२२१.९०२,२४५.००२,२१५.२०२,२३३.१०२.५५L
2026-04-20२,२४९.५०२,२५०.५०२,२१०.५०२,२३०.७०४.०८L
2026-04-17२,२४९.५०२,२७४.९०२,२४०.९०२,२४९.५०३.६६L
2026-04-16२,२६७.००२,२७३.८०२,२२८.६०२,२४९.५०४.३४L
2026-04-15२,२३०.९०२,२६५.००२,२०५.००२,२५८.४०६.१७L
2026-04-13२,१५३.४०२,२०५.००२,११५.१०२,१९३.१०७.२४L
2026-04-10२,१७३.९०२,१९८.९०२,१४८.९०२,१६३.२०६.६९L
2026-04-09२,१७३.५०२,१८६.२०२,१४२.००२,१६९.१०६.१३L
2026-04-08२,१६५.००२,१८७.००२,१२९.६०२,१७३.५०५.४५L
2026-04-07२,१००.००२,१३८.००२,०६८.२०२,११४.१०३.८८L
2026-04-02२,०८५.००२,०९८.४०१,९६६.५०२,०९१.८०९.७०L
2026-04-01२,१८०.००२,२३८.४०२,०८५.००२,१०१.१०१०.१२L
2026-03-27२,१६८.५०२,१८८.४०२,१४६.६०२,१७०.५०७.४४L
2026-03-25२,१२०.००२,१७९.७०२,१०२.४०२,१६८.५०४.४७L
2026-03-24२,१०३.००२,१३७.१०२,०७८.३०२,०९५.७०५.४०L
2026-03-20२,११४.१०२,१९०.९०२,११०.१०२,१८०.१०५.९७L
2026-03-19२,१७४.००२,१७६.६०२,०८७.४०२,०९७.५०४.६५L
2026-03-18२,१४५.९०२,२३७.६०२,१४३.१०२,१८६.३०८.८३L
2026-03-17२,१७९.९०२,१८४.७०२,१३६.००२,१४५.९०७.७४L
2026-03-16२,१७२.५०२,२१४.८०२,१४५.००२,१७५.४०५.२९L

अक्सर पूछे जाने वाले प्रश्न

के बारे में

ग्लेनमार्क फार्मास्यूटिकल्स लिमिटेड, एक भारत-आधारित फार्मास्युटिकल कंपनी है जिसका मुख्यालय मुंबई में है, जो सक्रिय फार्मास्युटिकल सामग्री (एपीआई) और फॉर्मूलेशन सहित जेनेरिक और विशेष दवाओं की एक श्रृंखला का डिजाइन, निर्माण और विपणन करती है, जो घरेलू और अंतरराष्ट्रीय दोनों बाजारों में सेवा प्रदान करती है। प्रमुख उत्पादों में हृदय, केंद्रीय तंत्रिका तंत्र विकारों और ऑन्कोलॉजी के उपचार शामिल हैं।

Advertisement
BOARD OF DIRECTORS
Anurag Mantri
Executive Director
DEPARTED
Anurag Mantri
Whole-time Director
Milind Sarwate
Independent Director
DEPARTED
Pradeep Kumar Sinha
Independent Director
Rajesh Desai
Independent Director
DEPARTED
Vijayalakshmi Rajaram Iyer
Independent Director